{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-088320","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.518579+00:00","generated_at":"2026-06-17T07:51:17.975611+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Tempest Therapeutics reports preliminary approval of OvaScience derivative settlement","bullets":["Cima v. Dipp derivative lawsuit settlement received preliminary court approval on March 23, 2023.","Upon final approval of the Cima settlement, a motion to dismiss the related Chiu v. Dipp action will be filed.","Settlement involves claims against OvaScience (predecessor) and former officers for alleged breach of fiduciary duties.","Settlement terms are described in a notice available on Tempest's investor website.","Litigation stems from OvaScience's January 2015 follow-on public offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-088320","json":"https://secwatch.observer/filing/0001193125-23-088320.json","markdown":"https://secwatch.observer/filing/0001193125-23-088320.md","text":"https://secwatch.observer/filing/0001193125-23-088320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312523088320/0001193125-23-088320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312523088320/d495297d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:51:17.975611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}